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Abstract
Objectives. Young people with inflammatory arthritis can have severe disease warranting biologic ther-
apy. They face complex treatment decisions, with profound consequences. This study aimed to explore
the influence of individuals outside the care team (trusted others) on the treatment decisions made by
young people, in particular their decisions about biologic therapies.
Methods. Young people (1625 years of age) with inflammatory arthritis and experience of treatment
decision making were recruited from three NHS Hospital Trusts. Twenty-five were interviewed, plus 11
trusted others identified by young people as being involved in their decision making, as well as 6 health
professionals. The data were analysed using coding, memoing and mapping techniques and the findings
were tested through a series of focus groups.
Results. Young people initially emphasized their decisional autonomy, typically describing people other
than health professionals as limited in influence. However, discussions revealed the involvement—in de-
liberation and enactment—of a range of other people. This cast of trusted others was small and largely
consistent; mothers played a particularly prominent role, providing cognitive, practical and emotional
support. Members of the wider cast of trusted others were involved in more limited but still significant
ways.
Conclusion. Young people claim autonomy but other people enable this. The network of relationships in
which they are embedded is distinctive and evolving. Mothers play a supporting role well into early
adulthood; in contrast, partners are involved in far more limited ways. As such, the applicability of adult
models of decision making is unclear. This must be taken into account if the support provided by pro-
fessionals is to be optimally tailored to young people’s needs.
Key words: young people, inflammatory arthritis, decision making, biologic therapies, trusted others,
interdependence, qualitative research.
Rheumatology key messages
. Young people claim autonomy in treatment decision making, but other people, especially mothers, enable this.
. Other people’s influence on young people’s treatment decisions may be significant without being obvious.
. In promoting independent decision making, care teams should take relationships with trusted others into account.
Introduction
Recent years have seen important changes in the clinical
management of inflammatory arthritis, in particular the
widespread use of biologic therapies in both paediatric
and adult services. Young people with aggressive disease
are more commonly being offered such treatments, and at
an earlier stage in the disease course [1]. The evidence
is clear that short-term benefits can be considerable,
and include reductions in joint pain and damage, plus
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improved mobility. However, there are also short-term
risks (e.g. increased vulnerability to infection), and the
long-term consequences of these treatments (e.g.
impact on fertility, risk of malignancy) remain uncertain
[2]. This is of particular concern for those who begin
taking them early in life. Young people offered biologics
are therefore confronted with a decision that may have
profound consequences, at a point when their disease
is at its worst and their wider lives are characterized by
change and uncertainty.
Health care professionals play an important role as pro-
viders of information and advice for patients generally [3]
and for young people specifically [4, 5]. However, treat-
ment decisions have also been shown to be influenced by
interactions with people outside the health care team
[6, 7]. In considering lay influence, the research literature
focuses substantially on the significant other, with this
term typically connoting a long-term partner or spouse
[8, 9]. Yet in the UK the trends are clear: people are com-
mitting to a partner much later than in the past [10, 11]. If a
growing proportion of young adults do not have a signifi-
cant other, focussing exclusively on this relationship as a
source of influence or support for decision making is
problematic. We therefore looked more broadly at the
who, how and why (or why not) of lay involvement in
young people’s treatment decisions. We refer to this
broader group of people as trusted others.
Methods
We report here on one component of a wider study of
young people’s decision making regarding biologics.
That study employed a range of qualitative methods: inter-
views (with young people, trusted others and health pro-
fessionals), recording of patient/professional interactions
and focus groups. The analysis reported here draws
principally on data from interviews, but is informed by
learning from other study strands and was validated in
the concluding focus groups. The study conformed to
National Institute for Health Research requirements
and had Research Ethics Committee approval from
the Proportionate Review Sub-committee, National
Research Ethics Service Committee Yorkshire &
Humber—Leeds East (ref. 12/YH/0122). All participants
gave consent verbally and in writing.
Setting
Potential interviewees (and participants in other research
strands) were identified and recruited via three NHS
Hospital Trusts, two in the North East of England and
one in the West Midlands. These trusts operated one or
more of the following rheumatology services: adult clinics,
young adult clinics run by adult and/or paediatric rheuma-
tologists with interests in adolescence and adolescent
clinics run by paediatric rheumatologists.
Sample
Our approach to sampling was purposive, seeking to
encompass variation in demographic characteristics,
diagnosis and treatment history (see Table 1) and to ex-
plore emerging conceptual issues. Requests were made
to direct care colleagues to identify and approach young
people with specific characteristics. Young people (n= 25)
were between 16 and 25 years of age at the first interview
and had a diagnosis of inflammatory arthritis (either JIA,
AS, PsA or RA). At first contact they either had not yet
been offered a biologic (n= 5), had recently been offered a
biologic (n= 5) or already had some experience with one
or more biologics (n= 15). Where young people’s treat-
ment status changed, i.e. as they started taking a first or
subsequent biologic, attempts were made to re-interview
them.
Trusted others (n= 11) were identified by participating
young people and approached through them. Most
agreed to participate and this subsample of interviewees
included eight mothers, one father, one grandmother and
one partner. Trusted others who declined to participate
included a close friend and a partner. Health professional
interviewees (n= 6) were identified by the core research
team and chosen to include key roles within the multidis-
ciplinary teams at the participating trusts and their service
providers.
Data collection
R.I.H. interviewed 25 young people, 5 on more than one
occasion, plus 11 trusted others and 6 health profes-
sionals. None of the interviewees had encountered R.I.H.
prior to the start of the project. In five cases, young people
and trusted others were interviewed together; in all other
instances interviewees were spoken to individually.
Interviews were semi-structured, lasted 40120 minutes
and were predominantly conducted face to face at a
location of the participant’s choice. Interview schedules
were initially informed by the team’s experience and a
review of the literature. These were adjusted to take ac-
count of individual circumstances (e.g. young people’s
treatment status) and refined following each round of ana-
lysis. All interviews were recorded, transcribed verbatim










Age, mean (range), years 20 (1625)
Disease duration, mean (range), years 9 (<1>20)
Rheumatology service accessed, n
Adult clinic 10
Young adult clinic 8
Adolescent clinic 7
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and anonymized. Field notes were written after each con-
tact and provided an additional resource for analysis.
Data analysis
The study data comprises 52 transcripts (of which 44
relate to interviews). These were closely and systematic-
ally examined by R.I.H. using open and focused coding,
mapping and memoing techniques to identify, classify,
label and relate themes, phenomena and ideas [12, 13].
Data segments (selected transcripts or data pertaining
to a particular theme) were similarly analysed by T.R.
Analyses were compared, shared and developed further
with other researchers in fortnightly data clinics, biannual
team and steering group meetings and a concluding
series of focus groups. These four focus groups com-
prised young people (n= 7, n= 3), trusted others (n= 4)
and health professionals (n= 8). They were a vehicle for
establishing face validity, providing a forum in which re-
search participants and their peers could comment on the
intelligibility, credibility and significance of the findings.
Results
My decision . . . but: stories of enabled autonomy
In the following sections we report on the involvement
of others in young people’s treatment decision making
and look in detail at four important roles these trusted
others play. Overall the message is one of qualified auton-
omy, encapsulated by the recurrent expression ‘my deci-
sion . . . but’. This echoes research into young people’s
experiences of treatment decision making in other clinical
areas [4, 14, 15]. However, while the findings of those
studies suggest constraint, the stories emerging from
our data were largely about enablement.
In general, young people in our study began by empha-
sizing their autonomy, typically describing people
other than health professionals as limited in influence.
However, in subsequent discussion they revealed the in-
volvement of a number of other people in the making and
making possible of treatment decisions. A mapping exer-
cise (Fig. 1) showed this cast of individuals with influence
to be relatively small and largely consistent. All relation-
ships had foundations in the real world and the group was
dominated by close family. Mothers played a particularly
prominent role in the accounts, as detailed in the following
subsection.
Trusted (m)others: I’ve always had me mam there
Mothers featured prominently in stories of making and
enacting decisions in around three-quarters of cases.
The majority of these young people (17/20) were living
under the same roof as their mother at the time of the
research. In two further instances, where the young per-
son’s mother was not able to play such a significant role,
someone else (a father and a grandmother) had stepped
in. The small minority of young people who did not ac-
knowledge the role of a mother, or stand-in, had distinct-
ive characteristics, typically having adult-onset conditions
that had been diagnosed after leaving home and/or
moving in with their partner. In essence, these were
young people who were organizing their lives like adult
patients.
Mothers are distinctive for the centrality of their role and
for the variety of ways in which they are involved in deci-
sion making. It is common for them to be implicated in
both deliberation and enactment, and their involvement
spans practical, cognitive and emotional realms (see
Fig. 2).
Examples of practical support include facilitating
access to services and enabling (sometimes enforcing)
the following through of decisions made in clinic. Young
people and trusted others explained how mothers were
FIG. 1 Trusted others featured in our data set
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involved in some or all of the following tasks: making ap-
pointments; taking the young person to the hospital;
ordering, receiving and storing medications and preparing
and in some instances administering injections. It was
exceedingly rare for anyone else to be involved in the
more intimate of these tasks (e.g. administering injec-
tions). Young people understood that treatment regimes
impacted on their mothers as well as themselves; a
change in treatment was therefore seen by some young
people as having the potential to help them both.
Mothers were also portrayed as supporting and contri-
buting to the cognitive aspects of decision making. This
included prompting or asking questions, doing research,
providing information and checking understanding. In
many instances they accompanied the young person to
consultations—as such they provided a backup or aide-
me´moire and were uniquely positioned to discuss the pros
and cons of the option(s) presented to the young person.
They also acted as a conduit, relaying information to other
members of the family on the young person’s behalf.
Mothers additionally offered emotional support to con-
front an important decision at a difficult time, essentially
being there for the young person and providing reassur-
ance, comfort and encouragement. However, young peo-
ple’s choices regarding where to turn for emotional
support were complex. They sought at times to protect
their parents (who often felt responsible for decisions
made, delays in diagnosis and sometimes the condition
itself), looking elsewhere to meet their emotional needs.
Wider family: in-house experts
Members of the wider (non-nuclear) family appear to have
defined but decisive roles when, in addition to ties of
blood or marriage, they can claim relevant professional
expertise. For example, young people talked of step-
parents, an aunt and a cousin who were nurses, or allied
health professionals. Young people often viewed this in-
house expertise as a valuable resource. These extended
family members typically had limited practical involve-
ment, but were providers of information and advice
about both the young person’s condition and potential
treatment options. As such, they were in a position to
substantially and directly influence treatment decisions.
A young person (male, 25 years old, diagnosis of AS)
first interviewed in the early stages of the project provides
a good example of this. This young man had recently
transferred into the Trust, though he had had the condition
since his late teens. He had met his consultant just once at
the time of the first interview and was taking NSAIDs.
Biologics had not been discussed. However, in the inter-
view it emerged that he already knew about them and
hoped to discuss these treatments with his consultant
at his next appointment. Further questioning revealed
that he had learnt about this group of drugs from his
cousin, the young man explaining: ‘My cousin, she’s
a nurse . . . she’d actually written down some names of
drugs to suggest . . . So she’s had a bit of an influence
too’. A few months after that interview he saw his consult-
ant again and subsequently began taking adalimumab.
A second interview was arranged in order to explore
the circumstances of the treatment offer and decision.
It transpired that (like several other interviewees with the
same diagnosis) he had been given a choice of biologic.
The young man explained his decision as follows:
adalimumab was ‘the one I was recommended from my
cousin . . . so I just plumped for that’.
FIG. 2 Mothers’ involvement in and influence on treatment decisions
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Empathic friends: someone I can talk to
Offering a quite different—but still highly valued—kind of
expertise are friends (or family members) with personal
experience of ill health. These people influence orientation
to new treatment options and provide support to manage
the emotions associated with starting new regimes with
uncertain outcomes. About a third of the young people in
our sample identified one or more friends of a similar age
(occasionally their boy-/girlfriend) who had their own
direct experience of ill health and with whom they felt
able to share quite intimate details of their illness experi-
ences and treatment dilemmas (see Fig. 3). These friends
had a variety of conditions, including kidney failure, dia-
betes, arthritis and migraines. They demonstrated three
important qualities that set them apart from interviewees’
other peers. First, these friends had a more grounded
understanding of their experience and capacity for em-
pathy. Secondly they had knowledge of the organization
of health services and medicine. Thirdly, their own difficul-
ties provided opportunities for reciprocity. This sense of
being able to help, rather than burdening each other, was
clearly important to the young people in our study; this
accords with the emphasis of other authors on reciprocity
as the key component of friendship [16].
In contrast, young people appeared hesitant, and
highly selective, regarding discussing either their treat-
ment or condition with their wider/healthy peers. Some
admitted this quite frankly. Others had their claims of
being open about their condition challenged by a trusted
other, subsequently qualifying their account. When
probed, concern was expressed about how peers would
respond. Some young people already had negative ex-
periences of disclosure; others anticipated these. It was
important to young people to be seen as normal, not as
different in any significant way from their peers. However,
they also talked of struggling to convey information about
their condition and other people’s struggles to under-
stand. This inability to comprehend the nature of their
condition made the idea of involving healthy peers in de-
liberations about treatment and care look quite pointless.
Supportive partners: someone to put the foot up your
backside
Almost half of the young people interviewed mentioned a
boy-/girlfriend, fiance´(e) or spouse, with six saying they
were living together. However, partners rarely featured
prominently in young people’s accounts of treatment de-
cision making. No examples were found of partners pro-
viding practical support (e.g. with receipt, storage,
preparation or administration of medications); where this
was needed, young people turned to their mothers.
Cognitive involvement also appeared modest, with
young people using their partner, at most, as a sounding
board. Where partners’ involvement was consistently re-
ported was as providers of encouragement, motivation
and discipline. A trusted other, whose son had lived
away from home for some time, commented that people
tend to get lazy with their health and the attention of
someone who cares is of real value. Regarding his own
son he said, ‘His partner now is, you know, nagging him
more than I did—and he takes it better!’
FIG. 3 The importance of friends with similar problems
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Although young people typically said their partner knew
about their condition, what that meant in practice seemed
to vary considerably. It was rare for them to take their
partner to hospital—just one of our interviewees reported
that her boyfriend routinely attended consultations.
Another said they would welcome their partner along,
and some suggested they might involve their partner fur-
ther if and when they considered starting a family. Most,
however, expressed a clear preference to see the consult-
ant alone, allowing them to manage the information their
partner received and maintain control over any decisions
made.
A few young people said they had been encouraged by
health professionals to share information with their part-
ner. They had found this advice valuable, if hard to follow.
Several admitted to playing down their difficulties, saying
they did not want to be fussed over or to let their partner
down. So, on balance, partners appear relatively poorly
informed. Fluctuations in a young person’s health, treat-
ment regimen and responses might be observed, but are
far from fully understood.
Discussion
Young people with inflammatory arthritis who are con-
fronted with decisions about biologic therapies vary
along multiple dimensions. In addition to demographic
variation, significant differences are evident in their dis-
ease trajectories and treatment histories. Despite these
differences, however, we see commonalities of experi-
ence that draw them together as a group and set them
apart from the more typical (older) rheumatology patient.
It is clear that while young people claim decisional au-
tonomy, and a small minority are justified in doing so,
most exhibit a relational autonomy. Their autonomy is
enabled by others who shape and support the making
and enactment of decisions. This is true for adults
too—the literature suggests that autonomy is enabled
across the life course—but different people are involved,
in different ways [6, 7, 17, 18], and critically, attitudes
towards their involvement are different.
Our study found that mothers often remain involved in a
wide range of ways well into early adulthood, in particu-
lar—but not exclusively—where their child is diagnosed
while a child. Young people in whose stories mothers
(or a stand-in from within the close family) do not play a
prominent role were a small and distinctive minority in our
study. All had adult-onset conditions, but in addition
had been diagnosed after leaving home and/or starting
to cohabit with a partner. These were young people who
were organizing their wider lives in an adult way.
Partners replaced parents as the first port of call in a yet
smaller minority of our cases (a situation noted in other
recent studies [19]). The role they take on is typically much
narrower than that of mothers, and careful management of
information, or partial disclosure, appears the norm. In line
with previous research on disclosure (of genetic risk) in
dating [20], our data suggest that sharing information
with partners is seen as risk-laden and difficult.
As previously pointed out elsewhere [21], insufficiency of
information can cause relationship tensions and lead
to misguided support for patients. Help to think through
whether, when and what information to share with
their partners (and indeed healthy peers) might benefit
some young people both emotionally and, ultimately,
clinically.
While relationships with healthy people are important
[22], friendships with other people with chronic illnesses
were highly valued by the young people in our study. On
occasion their experiential knowledge directly informed
treatment decision making. These relationships also
appear to have wider and potentially lasting benefits
[23, 24]. Friendship choices are rarely the preserve of in-
dividuals alone [25], hence the position taken here by care
teams (and others) is important. The case for recognizing
and the potential for facilitating the development of friend-
ships with other young people with inflammatory arthritis,
or chronic illnesses more widely, is worth exploring
further.
The involvement of others is normal, not dysfunctional,
and for patients in other age groups is largely accepted, if
not entirely approved. Young people need staunch allies,
and for many of the young people in our study (as sug-
gested elsewhere [26]) their mother continues to be the
best candidate. However, unlike older patients, young
people are encouraged, if not required, to demonstrate
independence in various ways [19]. While recognizing
the importance of work to empower young patients, we
believe considerable care needs to be taken to promote
independence without forcing supportive relationships
underground. We acknowledge that paediatric teams
are increasingly working towards interdependence,
where young people take responsibility for themselves
but parents continue to function as consultants [27].
Our data also offer a reminder that young people cannot
rely equally on their parents for support and guidance.
They may be disadvantaged by family structure [28] or
by resources [29]. Simmons et al. [15] draw our attention
to young people within the care system who may have
autonomy forced upon them. These, and other young
people whose families are struggling or fractured, may
benefit from additional professional attention and support.
Critically, interactions outside the clinical consultation
matter, but while the patterns highlighted here provide
a prompt to question received wisdom and taken-
for-granted practices, they do not tell us who influences
treatment decisions, and how, in any particular case.
Hence exploring home and peer relationships using
screening tools such as the Home, Education/
Employment, Activities, Drugs, Sexuality, Suicide assess-
ment tool [30] should be routine practice for all young
people.
Being clear who is involved, and how, is important for
several different reasons. First, it is the only way to make
sure everyone involved has appropriate informa-
tion—something that Elwyn et al. [31] have argued is a
fundamental component of effective shared decision
making. Secondly, such clarity equips the health care
team to foresee challenges and pre-empt potential
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problems (e.g. on the young person moving away from
home). Finally, it will help professionals identify the need
for and opportunities to build independence at a pace
appropriate to an individual’s needs. Fundamentally the
distinctive and evolving network of relationships in which
young people are embedded must be revealed and taken
into account if the support provided to them by profes-
sionals is to be most effectively tailored to their needs.
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